Tilray recalls ‘select batches’ of cannabis extracts in Germany

British Columbia, Canada-based Tilray is recalling a small amount of medical cannabis in Germany because of incorrect THC content, German independent pharmaceutical newspaper DAZ reported.

The product is THC10:CBD10,  a full-spectrum oil with 10 milligrams per milliliter of THC and 10 milligrams per milliliter of CBD.

“Tilray has initiated a voluntary recall of select batches of its Full Spectrum T10C10 medical cannabis oil supplied to German partners on March 20, 2020,” a spokeswoman for the company told Marijuana Business Daily.

“The company has initiated the recall due to slightly lower than indicated THC potency level identified in a routine stability test.”

She emphasized that “there is no patient safety impact. Patients and physicians are not required to take any action but do have the option to initiate a return of the product if they chose.”

According to DAZ, pharmacies were told to:

• Destroy the affected products.
• Inform Tilray distribution partner Paesel & Lorei about the destruction.
• Wait for replacement products.